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 Xinhua Chen, Thomas P. Stein, Theresa O. Scholl, Robert A. Steer 
 
  
 
• Inflammatory response changes during normal pregnancy in parallel with an 
increased level of circulating free fatty acids (FFAs).  
• Data in non-pregnancy studies suggested that chronic inflammation plays an 
important role in many of the chronic diseases, and certain FFAs are involved 
in inflammation and its resolution.  
• Data in healthy pregnant women between the relationship of FFAs 
composition with markers of inflammation have not been extensively 
examined. 
 
 
We investigated the relationship between maternal fasting plasma free fatty 
acids (FFAs) composition and markers of inflammation (MOI) (IL-6, 8, 10, TNF-α, 
granulocyte macrophage colony-stimulating factor (GMCSF) and resistin) in 
healthy pregnant women during early gestation (week 16). 
  
 
 
 
 
 
Introduction 
Objective 
Statistical analysis 
Design and Methods 
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Log transformation was used for calculation of means and SEM for skewed 
distributions of MOI measurements.  
ANOVA and multiple regression analysis were performed to evaluate the 
relationship between MOI (dependent variable) and individual FFA (expressed as 
percentage of total FFAs, independent variable). 
Potential confounding variables including maternal age, pre-pregnant BMI, 
ethnicity, parity, cigarette  smoking were controlled in multivariable models..  
Characteristics of participants (n=1,562)  
Negative relationship between myristic acid and markers of 
inflammation  
* P for trend <0.0001 for each    
Positive relationship between palmitic acid and markers of 
inflammation 
** 
Relationship of selected FFA and IL-8  
In normal pregnant women during early gestation, plasma 
saturated FFA (palmitic acid) and polyunsaturated long-chain 
FFAs (DGLA, arachidonic acid and EPA)  (expressed as percentage 
of total FFA) were significantly positively associated with IL6, 8, 
TNF-α and resistin.  
 
In contrast, plasma palmitoleic acid, oleic acid, linolenic acid and 
myristic acid were inversely associated with IL6, 8, TNF-α and 
resistin.  
 
Summary 
Conclusions 
• A prospective observational cohort study of pregnancy outcome and 
complications in young, generally health women residing in Camden, NJ 
(n=1,562). Women who developed gestational diabetes during late gestation 
were excluded to the analysis. 
• Blood samples collected at entry to prenatal care (16 weeks) were analyzed.  
• Serum markers of inflammation (IL-6, 8, 10, TNF-α, GMCSF, resistin) were 
measured by multiplex kits (Magpix) using the Luminex xMap Technology.  
 
FFAs name  FFAs abbreviation 
Myristic Acid MA 
Palmitic Acid  PA 
Palmitoleic Acid  PO 
Oleic acid  OA 
Stearic Acid  SA 
Linoleic Acid  LA 
α-Linolenic Acid  ALA 
Dihomo-γ-linolenic acid  DGLA 
Arachidonic acid  AA 
Eicosapentaenoic acid  EPA 
Docosahexaenoic acid  DHA 
FFAs identified by GCMS 
Characteristic Mean ± SD or n (%) 
Age (yr.) 21.88 ± 5.17  
Pre-pregnant BMI (kg/m2)  25.55 ± 6.14  
Obesity (BMI ≥30)  n (%) 303 (19.39) 
Nulliparous n ( % ) 602 (38.54) 
Ethnicity n (%) 
Hispanic 767 (49.10) 
African American 573 (36.68) 
Caucasian & other 222 (14.21) 
Cigarette smoking n (%)  291 (18.63) 
Medicaid n (%) 1548 (99.10) 
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These data suggested that maternal functional long-chain FFAs 
influence inflammatory response during normal pregnancy. 
Changing in specific FFA composition by modification of dietary 
intake of FAs may reduce low-grade inflammation and 
inflammation related poor pregnancy complications.  
